Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Prior clinical trials have demonstrated promising efficacy and manageable safety of surufatinib in neuroendocrine tumors (NETs). This real-world study aims to evaluate the clinical efficacy and safety of surufatinib in patients with NETs, providing additional real-world evidence to support clinical application, guide novel therapeutic strategies, and ultimately improve patient outcomes.
Epistemonikos ID: b4778585a5b880119461b10ac6f6324820735ff3
First added on: Aug 21, 2026